// App-Quantinova.ai

4384 : Selective cross-cohort discovery of transcriptional mechanisms presiding over high-risk neuroblastoma subtype state maintenance

Researchers

Presenter

  • Presha Rajbhandari

Principal Investigators

  • Gonzalo Lopez

  • Jiyang Yu

  • Ruth Rodriguez-Barrueco

  • Mariano Alvarez

  • Daniel Martinez

  • Mark Yarmarkovich

  • Jo Vandesompele

  • Pieter Mestdagh

  • Jose M. Silva

  • Anna Lasorella

  • Antonio Iavarone

  • John M. Maris

  • Andrea Califano

Medical Centers

  • Columbia University, New York, NY

  • Pfizer Inc, Pearl River, CA.

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • University of Pennsylvania, Philadelphia, PA

  • Ghent University Hospital, Ghent, Belgium

Locations

  • United States

  • Belgium

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroblastoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved